This is the first of a two part series on the topic of immune-mediated hemolytic anemia (IMHA) in dogs - a disease that significantly impacts their wellbeing and is an important cause of mortality in affected dogs. This program will serve to empower our audience to make informed decisions regarding the care and management of dogs diagnosed with IMHA. In this first segment the discussion includes:
- How to recognize possible IMHA and properly diagnose the disease
- How to differentiate important types of IMHA and how this can affect making the diagnosis and treatment recommendations for affected patients
- Standard therapy for treating IMHA with glucocorticoids
- Transfusion medicine for managing anemic patients
Running time: 1 hr 28 mins (including 15 mins of question / answer)
Approved for 1.5 hrs of CE credit by AAVSB RACE and NY State
You might also like
Improving The Quality Of Life For Cats With Chronic Kidney Disease
09/23/2025
Chronic kidney disease (CKD) is one of the most common and challenging conditions affecting older ca...
Read
More
Managing Liver Disease In Dogs: Nutrition And Supportive Care With Hepatoprotectants
12/17/2024
This webinar focuses on how to best manage dogs with liver disease through nutritional support and u...
Read
More
Gallbladder And Biliary Disease In The Dog
12/12/2024
The focus of this presentation is on diseases of the gallbladder and bile duct. Dr. Levei...
Read
More
Copper-associated Liver Disease In The Dog
12/10/2024
This segment focuses on copper-associated liver disease in dogs - a problem that has been on the ris...
Read
More
Protein-Losing Enteropathy - Therapeutic Management And The Crucial Role Of Nutrition
09/17/2024
In this second session (of a two part series) Dr. Jablonski continues the discussion on patient mana...
Read
More
Protein-Losing Enteropathy In Dogs - Making The Diagnosis
09/10/2024
In this first session (of a two part series) Dr. Jablonski creates a comprehensive understanding of...
Read
More
